ANKTIVA plus BCG is the first immunotherapy for non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with ...

Danielle Fishel said she is feeling positive about her health while speaking exclusively with PEOPLE at iHeartRadio's 102.7 ...

The higher the deduction, the lower the payout ratio in insurance claims, which often leads the family to bear significant ...

Danielle Fishel shared that following the completion of her breast cancer treatment, she's feeling healthy and positive ...

The actress was diagnosed with ductal carcinoma in situ (DCIS), an early stage of breast cancer, in August last year. She ...

Danielle Fishel has "a lot to be grateful for" after completing her breast cancer treatment.

The Boy Meets World alum, who is now in remission after a difficult journey, said she has been feeling 'grateful' about her ...

Danielle Fishel is sharing a positive update on her health after her breast cancer journeyIn a recent chat with People at ...

Investigators reported 1-year disease-free survival results from patients with BCG-unresponsive papillary disease-only high-risk NMIBC in the phase 2b SunRISe-1 trial.

Detailed price information for Artara Therapeutics Inc (TARA-Q) from The Globe and Mail including charting and trades.